Is protein p53 an independent prognostic factor in bladder carcinoma?
Keilholz, L.
Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft . 171(9): 543-544
1995
ISSN/ISBN: 0179-7158 PMID: 7570304 Document Number: 442715
Document emailed within 1 workday
Related Documents
Bharath, V.M.; Balagopal, P.G.; Nebu, A.G.; Jayasudha, A.V.; Iqbal Ahmed, M.; Sebastian, P. 2018: Can Metastatic Lymph node ratio be used as an independent prognostic factor in Carcinoma tongue? Gulf Journal of Oncology 1(28): 6-10Steiner, E.; Plata, K.; Interthal, C.; Schmidt, M.; Faldum, A.; Hengstler, J.G.; Sakuragi, N.; Watari, H.; Yamamoto, R.; Kölbl, H. 2007: Diabetes mellitus is a multivariate independent prognostic factor in endometrial carcinoma: a clinicopathologic study on 313 patients European Journal of Gynaecological Oncology 28(2): 95-97
Hemmer, J.; Nagel, E.; Kraft, K. 1999: DNA aneuploidy by flow cytometry is an independent prognostic factor in squamous cell carcinoma of the oral cavity Anticancer Research 19(2b): 1419-1422
Chang, Y.-s.; Huang, J.-s.; Yen, C.-l.; Wang, C.-h.; Lai, C.-h.; Wu, T.-h.; Lan, Y.-j.; Chang, P.-h.; Yeh, K.-y. 2015: The Charlson Comorbidity Index is an Independent Prognostic Factor for Treatment-Naïve Hepatocellular Carcinoma Patients with Extrahepatic Metastases Hepato-Gastroenterology 62(140): 1011-1015
Perentesis, J.P. 1997: Why is age such an important independent prognostic factor in acute lymphoblastic leukemia? Leukemia 11(Suppl): S4-S7
Roach, M. 1998: Is race an independent prognostic factor for survival from prostate cancer? Journal of the National Medical Association 90(11 Suppl): S713-S719
Hsu, M.M.; Chiou, C.R.; Ko, J.Y.; Sheen, T.S.; Hong, R.L.; Ting, L.L. 2000: DNA content of nasopharyngeal carcinoma: an independent prognostic indicator Cancer Detection and Prevention 24(2): 119-126
Jansen, R.L.; Hupperets, P.S.; Arends, J.W.; Joosten-Achjanie, S.R.; Volovics, A.; Hillen, H.F.; Schouten, H.C. 1998: pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer Anticancer Research 18(1b): 577-582
Cice, G.; Di Benedetto, A.; D'Andrea, A.; D'Isa, S.; De Gregorio, P.; Marcelli, D.; Gatti, E.; Calabrò, R. 2008: Heart rate as independent prognostic factor for mortality in normotensive hemodialysed patients Journal of Nephrology 21(5): 704-712
Vassilakopoulos, T.P.; Nadali, G.; Angelopoulou, M.K.; Siakantaris, M.P.; Dimopoulou, M.N.; Kontopidou, F.N.; Rassidakis, G.Z.; Doussis-Anagnostopoulou, I.A.; Hatzioannou, M.; Vaiopoulos, G.; Kittas, C.; Sarris, A.H.; Pizzolo, G.; Pangalis, G.A. 2001: Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma Haematologica 86(3): 274-281
Baekelandt, M.; Kristensen, G.B.; Tropé, C.G.; Nesland, J.M.; Holm, R. 1999: Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer Anticancer Research 19(5c): 4469-4474
Geisler, J.P.; Tammela, J.E.; Manahan, K.J.; Geisler, H.E.; Miller, G.A.; Zhou, Z.; Wiemann, M.C. 2004: HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up European Journal of Gynaecological Oncology 25(2): 165-168
Santala, M.; Talvensaari-Mattila, A. 2003: DNA ploidy is an independent prognostic indicator of overall survival in stage i endometrial endometrioid carcinoma Anticancer Research 23(6d): 5191-5196
Kaido, T.; Oe, H.; Yoshikawa, A.; Mori, A.; Arii, S.; Imamura, M. 2005: Tissue factor is a useful prognostic factor of recurrence in hepatocellular carcinoma in 5-year survivors Hepato-Gastroenterology 52(65): 1383-1387
Popov, Z.; Hoznek, A.; Colombel, M.; Bastuji, S.; Abbou, C.C.; Chopin, D.K. 1996: Evaluations of protein p53 overexpression in cancer of the bladder: prognostic value Chirurgie; Memoires de l'Academie de Chirurgie 121(6): 461-469
Aoyama, T.; Kazama, K.; Murakawa, M.; Atsumi, Y.; Shiozawa, M.; Kobayashi, S.; Ueno, M.; Morimoto, M.; Yukawa, N.; Oshima, T.; Yoshikawa, T.; Rino, Y.; Masuda, M.; Morinaga, S. 2016: The Surgical Apgar Score Is an Independent Prognostic Factor in Patients with Pancreatic Cancer Undergoing Pancreatoduodenectomy Followed by Adjuvant Chemotherapy Anticancer Research 36(5): 2497-2503
Day, C.L.; Sober, A.J.; Kopf, A.W.; Lew, R.A.; Mihm, M.C.; Golomb, F.M.; Hennessey, P.; Harris, M.N.; Gumport, S.L.; Raker, J.W.; Malt, R.A.; Cosimi, A.B.; Wood, W.C.; Roses, D.F.; Gorstein, F.; Fitzpatrick, T.B.; Postel, A. 1981: A prognostic model for clinical stage i melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease Surgery 89(5): 599-603
Belloso, L.; Zugasti, A.; Urkia, M.; Arozena, F.; Blasco-Olaetxea, E. 1997: The proliferating nuclear fraction as a prognostic factor in superficial bladder carcinomas Archivos Espanoles de Urologia 50(8): 831-836
Gao, C.; Yao, S.-K. 2009: Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma? Hepatobiliary and Pancreatic Diseases International: Hbpd Int 8(5): 465-473
Casetta, G.; Gontero, P.; Russo, R.; Pacchioni, D.; Tizzani, A. 1997: p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder European Urology 32(2): 229-236